Literature DB >> 16618616

Hemothorax due to metastatic hepatocellular carcinoma presenting with massive hemoptysis.

Yu-Feng Wei1, Hao-Chien Wang, Yi-Chen Chang.   

Abstract

Hemoperitoneum caused by ruptured hepatocellular carcinoma (HCC) is not uncommon in patients with HCC. Hemothorax due to rupture of metastatic HCC, however, is a very rare complication with high mortality because of uncontrollable hemorrhage. We describe a 42-year-old male HCC patient with chest wall metastasis complicated by hemothorax with an unusual presentation of massive hemoptysis. He received tube thoracotomy immediately and emergency surgery because of persistent bleeding. Hemostasis was achieved transiently. Despite intensive care, he died of multiple organ failure on the 6th postoperative day. We conclude that hemothorax due to a ruptured HCC, as in this case, indicates a very poor prognosis despite intensive treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16618616     DOI: 10.1016/S0929-6646(09)60127-3

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  Transcatheter arterial embolization for chest wall metastasis of hepatocellular carcinoma.

Authors:  Eiki Nagao; Masakazu Hirakawa; Hiroyasu Soeda; Satoru Tsuruta; Hironori Sakai; Hiroshi Honda
Journal:  World J Radiol       Date:  2013-02-28

2.  Hepatocellular carcinoma associated with hemorrhaging from iatrogenic rupture of a rib metastasis.

Authors:  Mitsuhiro Kamiyoshihara; Takashi Ibe; Izumi Takeyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-01-22

Review 3.  Hepatocellular carcinoma with thoracic metastases presenting as hemothorax: A case report and literature review.

Authors:  Chih-Wei Yen; Li-Sheng Hsu; Chien-Wei Chen; Wei-Hsiu Lin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 4.  Hemothorax caused by spontaneous rupture of hepatocellular carcinoma: a case report and review of the literature.

Authors:  Fuminori Ono; Masaki Hiraga; Noriyuki Omura; Manabu Sato; Akihiro Yamamura; Megumi Obara; Jun Sato; Shoichi Onochi
Journal:  World J Surg Oncol       Date:  2012-10-10       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.